Atlas Trials

A Randomized Double Blind Controlled Trial Comparing Sugammadex and Neostigmine After Thoracic Anesthesia

Clinical trial NCT02256280 · TERMINATED

Trial details

NCT number
NCT02256280
Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Neuromuscular Blockade
Start date
2015-01-01
Primary completion
2020-03-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.